If you think you may have symptoms of Coronavirus >, follow the national guidance and self-isolate for 10 days. Please see our information on Coronavirus and changes to our normal services >. If you, or a member of your family has tested positive for Coronavirus, please find resources to aid your/their recovery on our Coronavirus - Supporting your recovery > page.
From Monday 16 March 2020, recruitment of patients to all studies, other than those studies relating to COVID-19, will cease. This is to allow our clinical colleagues to focus their care where it is most needed. We are reviewing the trials we have open and are in contact with sponsors. The safety of our patients it always our priority.
The Derby Clinical Trials Support Unit is provisionally registered by the UKCRC CTU Network. We provide a bespoke service to researchers, sponsors and industry partners - including small and medium enterprises - through the design, delivery, analysis and reporting of high quality clinical research.
Whether you require support for a specific service or full project management and delivery, we can help.
Our clinical trials unit supports a wide range of studies and trials.
Take a look at some of the CTU studies and trials that are in set up, open or have been completed.
Derby Clinical Trials Unit is provisionally
registered by the UKCRC.
As a consultancy working with small and medium enterprises (SMEs) which innovate in healthcare, we recognise that our clients, seeking product validation through clinical trials, need to work with an organisation that is flexible, responsive, and cost-effective. For this reason we repeatedly refer clients to Derby Clinical Trials Support Unit, where our experience and client feedback is consistently excellent. I will not hesitate to continue such recommendations and referrals in future.
Kate Pym, Managing Director, Pym’s Consultancy.
I have found the Derby Clinical Trials Support Unit both friendly and very helpful.
I am very pleased that they agreed to look after the I-BiT Plus project.
Professor Alex Foss, Chief Investigator, I-BiT Plus study